Dachaigh › Aillse (gach seòrsa) › Texas › San Antonio
Sgrùdaidhean clionaigeach Aillse (gach seòrsa) ann an San Antonio, TX
Tha 41 sgrùdaidhean airson Aillse (gach seòrsa) a’ lorg phàirtichean aig làraichean ann agus timcheall air San Antonio (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study of ASP3082 in Adults With Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- PHN-012-001 Site, San Antonio
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
A’ fastadhÌre 1
- NEXT Oncology ( Site 0151), San Antonio
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
A’ fastadhÌre 2
- Mays Cancer Center ( Site 0039), San Antonio
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- GSK Investigational Site, San Antonio
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
A’ fastadhÌre 3
- START San Antonio ( Site 0104), San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A’ fastadhÌre 2/3
- Sam Clinical Research Center, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
A’ fastadhÌre 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
Prostate Active Surveillance Study
A’ fastadhSgrùdadh amharc
- University of Texas Health Science Center, San Antonio, San Antonio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A’ fastadhÌre 3
- Texas Oncology-San Antonio Cancer Care, San Antonio
- Texas Oncology - San Antonio Northeast, San Antonio
- Texas Oncology - San Antonio Stone Oak, San Antonio
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
Project: Every Child for Younger Patients With Cancer
A’ fastadhSgrùdadh amharc
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- Site 01, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
A’ fastadhÌre 1
- NEXT Oncology San Antonio, San Antonio
- START- San Antonio, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- UT Health Mays Cancer Center, San Antonio
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
A’ fastadhÌre 1
- START San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics, San Antonio
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
A’ fastadhÌre 3
- Texas Oncology San Antonio Medical Center, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- START San Antonio, LLC., San Antonio
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
A’ fastadhÌre 1
- USA Clinical Trials, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- START, San Antonio
CT-95 in Advanced Cancers Associated With Mesothelin Expression
A’ fastadhÌre 1
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
A’ fastadhÌre 1
- Research Site #2, San Antonio
- Research Site, San Antonio
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
A’ fastadhÌre 1
- GSK Investigational Site, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
A’ fastadhÌre 1/2
- NEXT Oncology, San Antonio
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT San Antonio, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology San Antonio, San Antonio
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- UT Health, San Antonio
A Study of YL242 in Subjects With Advanced Solid Tumors
A’ fastadhÌre 1/2
- US-207, San Antonio
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
A’ fastadhÌre 1/2
- NEXT Oncology, San Antonio
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
A’ fastadh
- University of Texas Health Science Center at San Antonio, San Antonio
Sgrùdaidhean Aillse (gach seòrsa) ann am bailtean eile
- Houston, TX121 sgrùdaidhean
- New York City, NY110 sgrùdaidhean
- Boston, MA86 sgrùdaidhean
- Los Angeles, CA73 sgrùdaidhean
- Nashville, TN65 sgrùdaidhean
- Philadelphia, PA59 sgrùdaidhean
- Durham, NC58 sgrùdaidhean
- Washington, DC58 sgrùdaidhean
- Chicago, IL51 sgrùdaidhean
- Seattle, WA49 sgrùdaidhean
- Atlanta, GA49 sgrùdaidhean
- Arlington, VA48 sgrùdaidhean
Sgrùdaidhean eile ann an San Antonio
- Aillse Sgamhain Neo-chealla-beag59 sgrùdaidhean
- Aillse colorectal46 sgrùdaidhean
- Aillse a' bhroilleach46 sgrùdaidhean
- Ailse metastatach44 sgrùdaidhean
- Obesity40 sgrùdaidhean
- Diabaitis Seòrsa 237 sgrùdaidhean
- Ro-throm34 sgrùdaidhean
- Cancer Ovarian31 sgrùdaidhean
- Cancer Pancreatic31 sgrùdaidhean
- Aillse Prostata28 sgrùdaidhean
- Ailse Endometrial27 sgrùdaidhean
- Ailseachadh nan Sgamhan26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.